Home › Therapeutic areas › Cardiovascular › Familial Chylomicronemia Syndrome

Familial Chylomicronemia Syndrome (1 companies)

Companies with an active program in Familial Chylomicronemia Syndrome.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
IONS Ionis Pharmaceuticals CardiovascularHematology+5 Rare 2 Approved $6.55B 29